Real-world treatment patterns and healthcare resource utilization among migraine patients: A German claims database analysis.

Charly GaulKarolin SeidelAlexander HeuckCarmina SilaidosThora MrosowskyAlice EberhardtBjörn FritzChristian Jacob

Published in: Journal of medical economics (2023)

Disease burden was high in patients receiving CGRP mAbs suggesting that patients treated preventively with CGRP mAbs shortly after product launch in Germany were severely affected chronic migraine patients. The same may be true for patients receiving BoNTA who also showed an increased disease burden.

Keyphrases

healthcare
end stage renal disease
ejection fraction
chronic kidney disease
prognostic factors
emergency department
combination therapy
health information